Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother’s own body. A Kobe University-led research team now found a treatment that drastically increases these women’s chances of carrying to full-term without complications.
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years
Lipoprotein(a), or Lp(a), was successfully reduced in phase II trials of muvalaplin and zerlasiran. (JAMA) The possibility of a drug interaction between SGLT2 inhibitors and
November 20, 2024